Recent News

• 08.14.2025 - Vyome closes Merger Transaction, Will Trade on Nasdaq as HIND Tomorrow
• 08.14.2025 - Vyome closes Merger Transaction, Will Trade on Nasdaq as HIND Tomorrow
• 08.13.2025 - Vyome Announces Nasdaq Approval of Merger with ReShape Lifesciences, Set to Begin Trading as HIND
• 08.13.2025 - Vyome Announces Nasdaq Approval of Merger with ReShape Lifesciences, Set to Begin Trading as HIND
• 08.12.2025 - Vyome Announces New Board of Directors with Deep MIT and AI Ties
• 08.12.2025 - Vyome Announces New Board of Directors with Deep MIT and AI Ties
• 08.07.2025 - ReShape Lifesciences Announces Shareholder Approval of Merger with Vyome Therapeutics
• 08.07.2025 - ReShape Lifesciences Announces Shareholder Approval of Merger with Vyome Therapeutics
• 07.24.2025 - ReShape Lifesciences® Announces Partial Adjournment of Special Meeting of Stockholders
• 07.24.2025 - ReShape Lifesciences® Announces Partial Adjournment of Special Meeting of Stockholders

Recent Filings

• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.14.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.13.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.11.2025 - 8-K Current report
• 07.30.2025 - 425 Prospectuses and communications, business combinations
• 07.25.2025 - 8-K Current report
• 07.25.2025 - 425 Prospectuses and communications, business combinations
• 07.24.2025 - 425 Prospectuses and communications, business combinations
• 07.24.2025 - 425 Prospectuses and communications, business combinations